Literature DB >> 3527251

Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.

A H Heagerty, A R Kennedy, I M Leigh, P Purkis, R A Eady.   

Abstract

LH 7:2 is a monoclonal antibody that was raised against an extract of human epidermal cells and identifies an epitope within the lamina densa of the basement membrane of stratified squamous epithelia. Using indirect immunofluorescence we found intense labelling with LH 7:2 at the epidermal basement membrane (EBM) of normal skin, and in skin samples from patients with simplex, junctional, dominantly inherited dystrophic and acquired forms of epidermolysis bullosa (EB), as well as bullous pemphigoid. Staining was absent or only very faint in generalized recessive dystrophic EB (RDEB), and patchily reduced in the localized form of RDEB. We conclude that LH 7:2 recognizes an EBM antigen which may be important in the pathogenesis of RDEB. Moreover, the antibody provides a useful probe for the rapid diagnosis of RDEB and is of special value in helping to discriminate between localized RDEB and typical dominant dystrophic EB--conditions which closely resemble each other clinically and which cannot be distinguished by means of transmission electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527251     DOI: 10.1111/j.1365-2133.1986.tb05707.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene.

Authors:  A Hovnanian; P Duquesnoy; C Blanchet-Bardon; R G Knowlton; S Amselem; M Lathrop; L Dubertret; J Uitto; M Goossens
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.

Authors:  A Hovnanian; A Rochat; C Bodemer; E Petit; C A Rivers; C Prost; S Fraitag; A M Christiano; J Uitto; M Lathrop; Y Barrandon; Y de Prost
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils.

Authors:  Daniela Villone; Anja Fritsch; Manuel Koch; Leena Bruckner-Tuderman; Uwe Hansen; Peter Bruckner
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 4.  Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology.

Authors:  R A Eady; M G Dunnill
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Very late antigen (VLA) expression in various forms of epidermolysis bullosa simplex.

Authors:  V Nazzaro; E Berti; R Cavalli; A Brusasco; R Caputo
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

6.  Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa.

Authors:  G Tadini; J Kanitakis; R Cavalli; D Schmitt; S Cambiaghi; E Berti
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

7.  Recurrent nonsense mutations within the type VII collagen gene in patients with severe recessive dystrophic epidermolysis bullosa.

Authors:  A Hovnanian; L Hilal; C Blanchet-Bardon; Y de Prost; A M Christiano; J Uitto; M Goossens
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

Review 8.  The molecular basis for inherited bullous diseases.

Authors:  B P Korge; T Krieg
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

9.  Distribution of type-VII collagen in xenografted human carcinomas.

Authors:  P Köpf-Maier; C Schröter-Kermani
Journal:  Cell Tissue Res       Date:  1993-06       Impact factor: 5.249

10.  Exclusion of linkage between the collagenase gene and generalized recessive dystrophic epidermolysis bullosa phenotype.

Authors:  A Hovnanian; P Duquesnoy; S Amselem; C Blanchet-Bardon; M Lathrop; L Dubertret; M Goossens
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.